BIOLOGICAL AND THERAPEUTIC SIGNIFICANCE OF C-MET PATHWAY IN OVARIAN CANCER

被引：0
|
作者：
Wang, K. L. [1 ]
Wu, C. C. [2 ]
Hsu, Y. T. [2 ]
Chang, C. L. [3 ]
机构：
[1] Taitung MacKay Mem Hosp, Dept Obstet & Gynecol, Taitung, Taiwan
[2] MacKay Mem Hosp, Dept Med Res, New Taipei, Taiwan
[3] MacKay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0159
引用
收藏
页码：655 / 655
页数：1
相关论文
共 50 条
  • [31] Progress in cancer therapy targeting c-Met signaling pathway
    Kyung Hee Jung
    Byung Hee Park
    Soon-Sun Hong
    Archives of Pharmacal Research, 2012, 35 : 595 - 604
  • [32] MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway
    Qu, Wanglei
    Chen, Xiaoyan
    Wang, Jiao
    Lv, Jieqiang
    Yan, Dongsheng
    CLINICA CHIMICA ACTA, 2017, 473 : 237 - 244
  • [33] The role of the HGF/c-Met signaling pathway in crizotinib-induced apoptosis in lung cancer with c-Met amplification
    Shaozhang Zhou
    Zhixin Dong
    Jinyi Lv
    Aiping Zeng
    Huilin Wang
    Ruiling Ning
    Xiangqun Song
    OncologyandTranslationalMedicine, 2017, 3 (03) : 116 - 126
  • [34] Development of c-MET pathway inhibitors
    Liu, Xiangdong
    Newton, Robert C.
    Scherle, Peggy A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (09) : 1225 - 1241
  • [35] c-Met pathway in brain tumors
    Guessous, Fadila
    Zhang, Ying
    Li, Yunqing
    DiPierro, Charles
    Kofman, Alex
    Schiff, David
    Abounader, Roger
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S62 - S62
  • [36] Biological significance of c-met over expression in papillary renal cell carcinoma
    Sweeney, P
    El-Naggar, AK
    Lin, SH
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 168 (01): : 51 - 55
  • [37] c-Met inhibition enhances chemosensitivity of human ovarian cancer cells
    Wang, Jing
    Cheng, Jian-Xin
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (01): : 79 - 87
  • [38] Clinical significance of c-met oncogene alterations in human colorectal cancer
    Umeki, K
    Shiota, G
    Kawasaki, H
    ONCOLOGY, 1999, 56 (04) : 314 - 321
  • [39] c-Met and miRs in Cancer
    Giglio, Simona
    Vecchione, Andrea
    BIOMEDICINES, 2015, 3 (01): : 32 - 44
  • [40] c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
    Christensen, JG
    Burrows, J
    Salgia, R
    CANCER LETTERS, 2005, 225 (01) : 1 - 26
12345